April 16, 2015 | The Israeli biomed company Foamix Pharmaceuticals announced that it raised $60 million in a secondary NASDAQ offering. Foamix is the developer of a foam-based delivery method for dermatological products and drugs. Foamix was founded in 2003 by Dov Tamarkind.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments